• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Prophylactic methylprednisolone for cardiac surgery in infants does not improve post-operative outcomes

byMinjee Kim
January 5, 2023
in StudyGraphics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In infants undergoing cardiopulmonary bypass surgery, prophylactic methylprednisolone use did not significantly reduce composite death, heart transplantation, complications, and prolonged hospital stay.

2. Prophylactic methylprednisolone use was associated with an increased risk of postoperative hyperglycemia. 

Evidence Rating Level: 1 (Excellent)

Study Rundown: Perioperative glucocorticoids have been used for decades to attenuate cardiopulmonary bypass-mediated systemic inflammation, but such use remains controversial. Several meta-analyses have provided conflicting information. Some suggest that mortality is lower with the use of perioperative glucocorticoids, while other meta-analyses showed no difference in mortality. Therefore, there is a gap in knowledge as to understanding the safety and efficacy of perioperative methylprednisolone in infants undergoing surgery for congenital heart disease. Overall, this study found that for infants younger than one year of age undergoing cardiac surgery, prophylactic use of methylprednisolone did not reduce the likelihood of a ranked composite of death, heart transplantation, major complications, and prolonged hospital stay. It was associated with an increased risk of postoperative hyperglycemia. This study was limited as enrolled patients were permitted to receive postoperative glucocorticoids. Additionally, registry data is not as accurate as data collected and placed into a traditional trial database. Nevertheless, these study’s findings are significant, as they demonstrate that prophylactic methylprednisolone for infants undergoing cardiac surgery provides no significant benefit in terms of outcome.

Click to read the study in NEJM

Relevant Reading: Halothane–Morphine Compared with High-Dose Sufentanil for Anesthesia and Postoperative Analgesia in Neonatal Cardiac Surgery

RELATED REPORTS

Mycobacterium abscessus infections after cardiac surgery linked to hospital water system

Hydrochlorothiazide does not impact risk of kidney-stone recurrence

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

In-Depth [randomized controlled trial]: This double-blind, randomized, placebo-controlled trial involved patients from 24 congenital heart disease centers in the United States. Patients who were undergoing elective cardiac surgery with cardiopulmonary bypass were eligible for inclusion if they were younger than one year of age. Patients who had an adjusted gestational age of fewer than 37 weeks at the time of surgery, had received any glucocorticoids within two days before surgery, had an infection contraindicating glucocorticoid use, or were receiving preoperative mechanical circulatory support were excluded from the study. The primary outcome measured was a composite of death, heart transplantation during hospitalization, or the occurrence of any of 13 individual major complications. Outcomes in the primary analysis were assessed via a proportional odds logistic regression model. Based on the primary analysis, the composite outcome did not differ significantly between the methylprednisolone group and the placebo group (adjusted odds ratio, 0.86; 95% Confidence Interval [CI], 0.71 to 1.05). Secondary analyses showed an odds ratio for the composite outcome of 0.82 (95% CI, 0.67 to 1.00) and a win ratio of 1.15 (95% CI, 1.00 to 1.32) in the methylprednisolone group as compared with the placebo group, findings suggestive of a benefit with methylprednisolone. However, patients in the methylprednisolone group were more likely than those in the placebo group to require postoperative insulin for hyperglycemia (19.0% vs. 6.7%). Overall, this study demonstrates that prophylactic use of methylprednisolone did not significantly reduce the likelihood of a worse outcome and was associated with a higher risk of developing postoperative hyperglycemia warranting insulin.

 

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: bypassCABGcardiac bypass surgeryCardiac surgerycoronary artery bypass surgery (CABG)infant mortalitymethylprednisoloneProphylactic methylprednisoloneSurgery
Previous Post

Haloperidol does not improve outcomes at 90 days in ICU patients with delirium

Next Post

Balanced intravenous solutions reduce risk of hyperchloremia in the pediatric intensive care unit

RelatedReports

Standardized central line care practices reduce bloodstream infections
Infectious Disease

Mycobacterium abscessus infections after cardiac surgery linked to hospital water system

March 23, 2023
Renal stones in women linked with increased risk of coronary heart disease
Nephrology

Hydrochlorothiazide does not impact risk of kidney-stone recurrence

March 22, 2023
Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Chronic Disease

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

March 20, 2023
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Public Health

Outpatient surgery trends during before and after the onset of the COVID-19 pandemic

March 11, 2023
Next Post
Hypotonic IVF linked to increased risk of hyponatremia

Balanced intravenous solutions reduce risk of hyperchloremia in the pediatric intensive care unit

Meeting families, demographic information affect child abuse work-up

Intimate partner violence associated with poor socioemotional development in children

FDA-approved weight loss medications associated with weight loss at one year

Christian Orthodox Church fasting may improve metabolic syndrome risk factors

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stroke may be associated with sleep disturbances in adults
  • Transcarotid artery revascularization not associated with a significant difference in 30-day risk of stroke, death and myocardial infarction compared to carotid endarterectomy
  • Drinking characteristics in adolescence predict alcohol behaviors in early adulthood
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options